Business Context and Reporting Period
Company: Acadia Healthcare Company, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 22, 2018
Event: Entry into a Material Definitive Agreement regarding debt refinancing.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or liquidity metrics. It focuses exclusively on debt restructuring terms.
| Debt Instrument | Previous Applicable Rate | New Applicable Rate |
|---|---|---|
| Tranche B-3 Term Loan (replacing B-1) | 2.75% (Eurodollar) / 1.75% (Base Rate) | 2.50% (Eurodollar) / 1.50% (Base Rate) |
| Tranche B-4 Term Loan (replacing B-2) | 2.75% (Eurodollar) / 1.75% (Base Rate) | 2.50% (Eurodollar) / 1.50% (Base Rate) |
Material Changes
- Debt Restructuring: The Company entered into a Second Refinancing Facilities Amendment to its Amended and Restated Credit Agreement (originally dated December 31, 2012).
- Loan Replacement: The Tranche B-1 and Tranche B-2 Term Loans were replaced by the Tranche B-3 and Tranche B-4 Term Loans, respectively.
- Interest Rate Reduction: The Applicable Rate was reduced by 25 basis points for Eurodollar Rate Loans (from 2.75% to 2.50%) and by 25 basis points for Base Rate Loans (from 1.75% to 1.50%).
Guidance, Outlook, and Risks
- Future Actions: Management continues to explore additional amendments and repricings of the Credit Agreement to benefit from current senior secured debt market terms.
- Uncertainty: There is no assurance that additional amendments or repricings will be completed on terms satisfactory to the Company.
- Forward-Looking Statements: The filing contains forward-looking statements regarding future refinancing efforts, which are subject to risks and uncertainties that could cause actual results to differ materially.
Investor Verification Checklist
- Verify the full text of the Second Refinancing Facilities Amendment (Exhibit 10) for covenants or conditions not summarized in the 8-K.
- Confirm the total principal amount of the Tranche B-3 and B-4 Term Loans to assess the total interest savings impact.
- Monitor future filings for the status of additional proposed amendments mentioned in Item 7.01.
- Review the Company's most recent 10-K or 10-Q for baseline debt levels and liquidity ratios, as this 8-K does not provide them.